Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

25.98 +0.97 (+3.88%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort ↗

May 29, 2025

The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ending a key Biden-era pandemic preparedness initiative. The cancellation...

Via Benzinga

Topics Government

Moderna Stock Drops On HHS Funding Termination For Pandemic Flu Vaccine; Retail Turns Bearish ↗

May 28, 2025

The setback adds to recent regulatory delays, prompting cautious sentiment among retail investors expecting further downside.

Via Stocktwits

Moderna Announces Update on Investigational Pandemic Influenza Program

May 28, 2025

Via ACCESS Newswire

10 Health Care Stocks Whale Activity In Today's Session ↗

May 28, 2025

Via Benzinga

Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children ↗

May 27, 2025

RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed.

Via Benzinga

How Is The Market Feeling About Moderna? ↗

May 20, 2025

Via Benzinga

Moderna to Present at Upcoming Conferences in June 2025

May 27, 2025

Via ACCESS Newswire

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

May 23, 2025

Via ACCESS Newswire

Discover which S&P500 stocks are making waves on Friday. ↗

May 23, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Friday's session: top gainers and losers in the S&P500 index ↗

May 23, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Where Moderna Stands With Analysts ↗

May 22, 2025

Via Benzinga

Top S&P500 movers in Thursday's session ↗

May 22, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.

Via Chartmill

Moderna Stock Looks Ripe for a Short Squeeze

May 22, 2025

Moderna stock has made single-digit gains in the last month, and high short interest suggests that any bullish news could cause a short squeeze

Via MarketBeat

Topics Government

Moderna Reverses Its Rally As It Faces Another Vaccine Setback ↗

May 21, 2025

The company previously guided to a longer timeline for its Covid/flu shot. But Wednesday's news introduces some data risk.

Via Investor's Business Daily

Moderna Pulls Application For Seasonal Flu, Covid Combination Vaccine: But Retail Gets More Bullish ↗

May 21, 2025

Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available.

Via Stocktwits

Hedge Funds Are Building A Towering Wall Of Bets Against Stocks ↗

May 21, 2025

After a sharp 23% rebound in the S&P 500 since April, hedge funds are now stacking record levels of bearish bets against stocks as investors question the staying power of the tariff-relief rally.

Via Benzinga

Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

May 21, 2025

Via ACCESS Newswire

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr. ↗

May 21, 2025

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter...

Via Benzinga

What's Going On With Vaccine Stocks Today? ↗

May 20, 2025

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed that its advisers will meet this week.

Via Benzinga

What's going on in today's session: S&P500 movers ↗

May 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Stay informed about the most active stocks in the S&P500 index on Tuesday's session. ↗

May 20, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Moderna (MRNA) Stock Trades Up, Here Is Why

May 20, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA announced new regulatory guidelines that still allow quick COVID vaccine approvals for seniors and...

Via StockStory

Topics Government World Trade

FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Rise ↗

May 20, 2025

The agency plans to demand stronger evidence of efficacy for the shots before approval is granted for healthy persons, between the ages of six months and 64 years, with no risk factors for severe...

Via Stocktwits

Exploring the top movers within the S&P500 index during today's session. ↗

May 20, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped. ↗

May 20, 2025

The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness.

Via Investor's Business Daily

Topics Bankruptcy Government

What's going on in today's session: S&P500 movers ↗

May 19, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday? ↗

May 19, 2025

U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest...

Via Benzinga

Topics Economy

Uncover the latest developments among S&P500 stocks in today's session. ↗

May 19, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment ↗

May 19, 2025

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.

Via Benzinga

Discover which S&P500 stocks are making waves on Friday. ↗

May 16, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.